Please read Holly Roo's Story about her son (Holly and Parker pictured above) and you will see how a trial drug, Arbaclofen, has changed her life and has impacted so many others living with autism and Fragile X. Arbaclofen has had amazing results for many participants yet Seaside Therapeutics has had to immediately terminate this trial without gaining FDA approval due to lack of funding. We hope that this story, and there are thousands more, can inspire pharmaceutical companies to see that it has been a lifesaver for so many families and can definitely be profitable!!